IP Library Granted Patent US 7,955,350
Granted Patent B2
US 7,955,350 · App. 10/810,330 · Granted Jun 7, 2011

Apparatus and methods for treating hardened vascular lesions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,955,350
App. No.
10/810,330
Granted
Jun 7, 2011
Kind
B2
Abstract

An angioplasty catheter comprises a catheter body having a balloon or other radially expansible shell at its distal end. A non-axial external structure is carried over the shell and scores a stenosed region in a blood vessel when the balloon is inflated therein. The catheter has an attachment structure disposed between the catheter body and the balloon to accommodate foreshortening and rotation of the external structure as the balloon is expanded. The external structure may be part of a helical cage structure which floats over the balloon.

Claims (10)

1. A method for delivering a drug to a blood vessel lesion, said method comprising:

introducing a catheter carrying a balloon into the blood vessel, wherein the drug is carried by the balloon as a platform;

inflating the balloon to radially expand a scoring cage comprising metal scoring elements slidably carried by said balloon, wherein the balloon inflation engages the scoring elements against stenotic material in the lesion to radially penetrate the stenotic material;

releasing a drug into the scored lesion to enhance delivery into the vessel wall;

deflating the balloon, wherein the metal scoring elements of the cage elastically close over the balloon as the balloon deflates; and

removing the catheter, the deflated balloon and the scoring cage from the blood vessel.

2. A method as in claim 1 , wherein releasing comprises embedding the drug through the stenotic material into the vessel wall.

3. A method as in claim 2 , wherein the drug is present in capsules.

4. A method as in claim 2 , wherein the drug is present in a drug-containing polymer.

5. A method as in claim 1 , wherein the scoring elements in the scoring cage are arranged helically over the expansible balloon.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0066 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0142 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: ANGIOSCORE INC.
Reel/Frame 037266/0474 →
SECURITY INTEREST (TERM) Recorded Dec 11, 2015
From: ANGIOSCORE INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037273/0804 →
SECURITY INTEREST (REVOLVER) Recorded Dec 11, 2015
From: ANGIOSCORE INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037273/0822 →
SECURITY INTEREST Recorded Jul 2, 2015
From: ANGIOSCORE INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 035973/0146 →